VEGFA and neoplasm: The lack of T cells, various mechanisms preventing T cell migration and invasion, low tumour mutation burden, low PD-1/PDL1 expression, hyper angiogenesis, and high expression of vascular endothelial growth factor (VEGF) are some of the main factors of clinical treatment’s poor effectiveness (12–15).